2023 Form 5500 filing — Astrazeneca Defined Benefit Pension Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015113116NAL0029410817001) for Astrazeneca Defined Benefit Pension Plan, reported by Astrazeneca Pharmaceuticals Lp under EIN 23-2967016 and plan number 001. It reports 5,825 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials).
Form 5500 2 · 2023
Filing snapshot
Net assets (EOY)$0Reported net assets
Participants5.8K5,825
Provider compensationNone reported
Schedules filedSchedule HLoaded schedules
- EFAST2 acknowledgement
- 20241015113116NAL0029410817001
- Plan sponsor
- Astrazeneca Pharmaceuticals Lp
- EIN
- 23-2967016
- Plan number
- 001
- Location
- Wilmington, DE
- Received date
- not reported in the loaded dataset
Schedule H · 2023
Reported financial snapshot
Reported figures as filed, in whole dollars. Only fields the filing reports are shown.
Full reported line items
- Total assets (EOY)
- $0
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $0
- Employer contributions
- $26,800,000
- Total income / additions
- $49,049,000
- Benefits paid
- $879,677,000
- Administrative expenses
- $0
- Total expenses
- $879,677,000
- Net increase / (decrease)
- -$830,628,000